We hypothesize that the engagement of the glucocorticoid receptor by dexamethasone in these co-expressing cell types reduces local and systemic IL-6 production, which in turn restores immune homeostasis and mitigates the progression of the COVID-19 associated acute respiratory distress syndrome. The gene discussed is NR3C1; the disease is COVID-19.